LAMA3 DNA methylation and transcriptome changes associated with chemotherapy resistance in ovarian cancer

被引：0
|
作者：
Li-yuan Feng
Yong-zhi Huang
Wei Zhang
Li Li
机构：
[1] Guangxi Medical University Cancer Hospital,Department of Gynecologic Oncology
[2] Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor,undefined
[3] Ministry of Education,undefined
来源：
Journal of Ovarian Research | / 14卷
关键词：
Ovarian cancer; Chemoresistance ; LAMA3 methylation; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer
    Meng Li
    Curt Balch
    John S Montgomery
    Mikyoung Jeong
    Jae Hoon Chung
    Pearlly Yan
    Tim HM Huang
    Sun Kim
    Kenneth P Nephew
    BMC Medical Genomics, 2
  • [42] Epidermal growth factor receptor mediated alterations in DNA methylation associated with the development of platinum resistance in ovarian cancer cells
    Samudio-Ruiz, Sabrina L.
    Granados, Michaela L.
    Hudson, Laurie G.
    CLINICAL CANCER RESEARCH, 2015, 21
  • [43] Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer
    Li, Meng
    Balch, Curt
    Montgomery, John S.
    Jeong, Mikyoung
    Chung, Jae Hoon
    Yan, Pearlly
    Huang, Tim H. M.
    Kim, Sun
    Nephew, Kenneth P.
    BMC MEDICAL GENOMICS, 2009, 2
  • [44] Single-cell transcriptome analysis of macrophage subpopulations contributing to chemotherapy resistance in ovarian cancer
    Zhong, Xiaolin
    Zhang, Fei
    Xiao, Hongyang
    Tu, Ruiqing
    IMMUNOBIOLOGY, 2024, 229 (05)
  • [45] Methylation and ovarian cancer: Can DNA methylation be of diagnostic use?
    Hentze, Julie L.
    Hogdall, Claus K.
    Hogdall, Estrid V.
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 10 (03) : 323 - 330
  • [46] Acquired chemotherapy resistance in ovarian cancer
    Christie, E. L.
    Bowtell, D. D. L.
    ANNALS OF ONCOLOGY, 2017, 28 : 13 - 15
  • [47] Mechanisms of chemotherapy resistance in ovarian cancer
    Ortiz, Mylena
    Wabel, Emma
    Mitchell, Kerry
    Horibata, Sachi
    CANCER DRUG RESISTANCE, 2022, 5 (02) : 304 - 316
  • [48] Knockdown of LAMA3 enhances the sensitivity of colon cancer to oxaliplatin by regulating the Hippo-YAP pathway
    Li, Jiqiang
    Yu, Yahui
    Zeng, Rong
    Zou, Yujiao
    Bu, Junguo
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2025, 1871 (03):
  • [49] HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
    Teschendorff, Andrew E.
    Lee, Shih-Han
    Jones, Allison
    Fiegl, Heidi
    Kalwa, Marie
    Wagner, Wolfgang
    Chindera, Kantaraja
    Evans, Iona
    Dubeau, Louis
    Orjalo, Arturo
    Horlings, Hugo M.
    Niederreiter, Lukas
    Kaser, Arthur
    Yang, Winnie
    Goode, Ellen L.
    Fridley, Brooke L.
    Jenner, Richard G.
    Berns, Els M. J. J.
    Wik, Elisabeth
    Salvesen, Helga B.
    Wisman, G. Bea A.
    van der Zee, Ate G. J.
    Davidson, Ben
    Trope, Claes G.
    Lambrechts, Sandrina
    Vergote, Ignace
    Calvert, Hilary
    Jacobs, Ian J.
    Widschwendter, Martin
    GENOME MEDICINE, 2015, 7
  • [50] Prognostic DNA methylation biomarkers in ovarian cancer
    Wei, SH
    Balch, C
    Paik, HH
    Kim, YS
    Baldwin, RL
    Liyanarachchi, S
    Li, L
    Wang, ZL
    Wan, JC
    Davuluri, RV
    Karlan, BY
    Gifford, G
    Brown, R
    Kim, S
    Huang, THM
    Nephew, KP
    CLINICAL CANCER RESEARCH, 2006, 12 (09) : 2788 - 2794
12345